P&G Wins Clairol Bid Without Swapping OTCs
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble appears committed to strengthening its OTC drug portfolio in the wake of the firm's successful bid for the Clairol hair care business.
You may also be interested in...
P&G ThermaCare $90 Mil. Ad Campaign Slated To Begin In January
Procter & Gamble's ThermaCare disposable pain-relief heat wraps will begin appearing beside oral analgesics nationwide in January.
P&G Pharma Asset Exchange For Bristol's Clairol Possible, Analyst Says
Procter & Gamble may be willing to "exchange part or all of its pharmaceutical assets along with cash" to acquire Bristol-Myers Squibb's Clairol business, Merrill Lynch analyst Heather Murren says in a May 4 report.
Crest WhiteStrips
Retail launch slated for May with ad support to follow, P&G says. About 300,000 kits have been sold over Internet, telephone, QVC since September and in dentists' offices since July for more than $10 mil.; $3.5 mil. in online sales is biggest Web launch for P&G, firm notes (1"The Tan Sheet" Sept. 18, p. 9). P&G estimates whitening kit market at $20 mil.-$25 mil. Drugstore.com offers advance ordering for WhiteStrips to ship May 7 free of mailing charges